Using an Online Patient Monitoring System to Improve Care for Children With Chronic Conditions
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Asthma, Depression, Depression, Neurology, Neurology, Psychiatric, Psychiatric, Psychiatric, Epilepsy, Autism |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 1/6/2019 |
| Start Date: | December 2014 |
| End Date: | December 2021 |
Integrated Clinical Information Sharing System: Implementation and Mixed-Methods Evaluation of a Web-based Monitoring and Management System for Patients With Chronic Conditions
TriVox Health is an online system designed to make it easy for healthcare providers to
monitor patients' disease symptoms and functioning over time and in between in-person visits
(http://www.youtube.com/watch?v=VR1vcbx0Ef4). Using combined quality improvement and
randomized clinical trial methods, we will evaluate the impact of TriVox on the health
outcomes, patient/family experience of care, and healthcare utilization for children and
adolescents with Attention Deficit Hyperactivity Disorder (ADHD), asthma, autism, depression,
and epilepsy.
monitor patients' disease symptoms and functioning over time and in between in-person visits
(http://www.youtube.com/watch?v=VR1vcbx0Ef4). Using combined quality improvement and
randomized clinical trial methods, we will evaluate the impact of TriVox on the health
outcomes, patient/family experience of care, and healthcare utilization for children and
adolescents with Attention Deficit Hyperactivity Disorder (ADHD), asthma, autism, depression,
and epilepsy.
TriVox Health is a web-based patient management and monitoring system designed to track
patients' disease symptoms and response to therapy over time. TriVox Health enables clinics
to use electronic surveys to gather data remotely from multiple responders, including
patients, parents/guardians, school personnel and ancillary providers, and view the responses
in a timely manner via graphical, tabular, and narrative summary formats.
This quality improvement (QI) initiative will implement TriVox as the standard of care for
all patients who receive care for ADHD, asthma, autism, depression, and epilepsy within seven
ambulatory specialties at Boston Children's Hospital. Patients and families will use TriVox
to report on patient health status and will complete clinically-reTriVoxlevant questionnaires
at routine intervals. Providers will use the information collected through TriVox to inform
their clinical care of the patient/family.
To evaluate the effectiveness of TriVox, we will conduct a 24-month phased, cluster
randomized controlled trial (RCT) where we randomize providers to "active" vs.
"delayed-start" to TriVox use, with patients clustered by provider (within specialties) for
analytic purposes. Delayed-start providers will crossover to active TriVox use after 12
months. Patients/families will complete additional surveys in order to assess the system's
actual or potential effects on patient/family-provider interactions, healthcare utilization
and costs.
patients' disease symptoms and response to therapy over time. TriVox Health enables clinics
to use electronic surveys to gather data remotely from multiple responders, including
patients, parents/guardians, school personnel and ancillary providers, and view the responses
in a timely manner via graphical, tabular, and narrative summary formats.
This quality improvement (QI) initiative will implement TriVox as the standard of care for
all patients who receive care for ADHD, asthma, autism, depression, and epilepsy within seven
ambulatory specialties at Boston Children's Hospital. Patients and families will use TriVox
to report on patient health status and will complete clinically-reTriVoxlevant questionnaires
at routine intervals. Providers will use the information collected through TriVox to inform
their clinical care of the patient/family.
To evaluate the effectiveness of TriVox, we will conduct a 24-month phased, cluster
randomized controlled trial (RCT) where we randomize providers to "active" vs.
"delayed-start" to TriVox use, with patients clustered by provider (within specialties) for
analytic purposes. Delayed-start providers will crossover to active TriVox use after 12
months. Patients/families will complete additional surveys in order to assess the system's
actual or potential effects on patient/family-provider interactions, healthcare utilization
and costs.
Inclusion Criteria:
- Pediatric patients with clinical diagnosis of ADHD, asthma, autism, depression, and/or
epilepsy
- Patient receives care for these diagnoses from providers in participating ambulatory
clinics (Primary Care, Adolescent Medicine, Developmental Medicine, Neurology,
Psychiatry)
- Patient's primary caregiver enrolled in TriVox
Exclusion Criteria:
We found this trial at
1
site
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
Click here to add this to my saved trials
